MIA:


  • WHO ATC First Level (Anatomical main group) ID: J ANTIINFECTIVES FOR SYSTEMIC USE
  • WHO ATC Second Level (Therapeutic subgroup) ID: J04 ANTIMYCOBACTERIALS
  • WHO ATC Third Level (Pharmacological subgroup) ID: J04B DRUGS FOR TREATMENT OF LEPRA
  • WHO ATC Fourth Level (Chemical subgroup) ID: J04BA Drugs for treatment of lepra
  • WHO ATC Fifth Level (Chemical substance) ID: J04BA02 Dapsone

  • Chemical Name: Dapsone
  • Chemical Smi: Nc1ccc(cc1)S(=O)(=O)c1ccc(cc1)N

  • WHO ICD Mapped Level : L13.0 L13.0 Name: Dermatitis herpetiformis
  • WHO ICD Fourth Level ID: L13.0 L13.0 Name: Dermatitis herpetiformis
  • WHO ICD Third Level ID: L13 L13 Name: Other bullous disorders
  • WHO ICD Second Level ID: L10-L14 L10-L14 Name: Bullous disorders
  • WHO ICD First Level ID: XII XII Name: Diseases of the skin and subcutaneous tissue